Clinical Trial Update: Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a double-treatment regimen of mebendazole plus quinfamide for intestinal helminthiasis and amebiasis in Mexico has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebiasis
• Helminthiasis

Drugs mentioned

• Mebendazole (Mebendazole)
• Quinfamide (Quinfamide)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Helminthiasis, Amoebiasis | Phase 4 | Status: COMPLETED